VPM1002 / Max Planck Institute, SAKK, Serum Institute of India  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
VPM1002 / SAKK, Serum Institute of India
NCT01479972: Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa

Completed
2
48
RoW
VPM1002, BCG
Vakzine Projekt Management GmbH, Children's Infectious Diseases Clinical Research Unit (KID-CRU), South Africa, Triclinium Johannesburg, South Africa, University of Stellenbosch, HJ-CTC George, South Africa
Tuberculosis
11/12
11/12
NCT02391415: Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa

Completed
2
416
RoW
VPM1002, recombinant BCG for TB, BCG, VPM1002(Hyg+)
Serum Institute of India Pvt. Ltd., Vakzine Projekt Management GmbH, Triclinium Clinical Trial Project Management, Children's Infectious Diseases Clinical Research Unit (KID-CRU), Desmond Tutu TB Centre, The Respiratory and Meningeal Pathogens Research Unit (RMPRU), South African Tuberculosis Vaccine Initiative, University of Stellenbosch
Tuberculosis
11/17
11/17
SAKK 06/19, NCT04630730: Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC

Recruiting
2
46
Europe
Recombinant intravesical BCG (Bacillus Calmette-Guérin VPM1002BC), VPM1002BC, Atezolizumab, Tecentriq™, Cisplatin, Platinol®, Gemcitabine, Gemzar ®
Swiss Group for Clinical Cancer Research
Bladder Cancer
06/26
06/30
SAKK 06/14, NCT02371447 / 2014-005330-58: VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer

Completed
1/2
39
Europe
VPM1002BC, Mycobacterium bovis BCG∆ureC::Hly+, VPM1002
Swiss Group for Clinical Cancer Research
Bladder Cancer
10/19
03/23
NCT05539989: Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa

Withdrawn
1/2
480
RoW
VPM1002 Vaccine, BCG Vaccine, Placebo
International Maternal Pediatric Adolescent AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases (NIAID), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH)
Tuberculosis, HIV Infections
07/27
07/27

Download Options